The @NHSEngland landmark decision to stop using puberty blockers for gender dysphoric youth raises a key question: what do we know about the effects of puberty blockers on adolescent development?
Prof. Sallie Baxendale explored this question at @segm_ebm 2023 conference./1🧵
"Extraordinary claims demand extraordinary evidence" wrote Prof. Baxendale in a piece describing her research. "The only extraordinary evidence here is the gaping chasm of knowledge, or even apparent curiosity, of the clinicians who continue to chant 'safe and completely reversible' as they prescribe these medications to the children in their care." /2 unherd.com/2024/02/why-di…
Following the preview of her research at @segm_ebm conference, Prof. Baxendale published her findings about the known effects of puberty blockers
on neuropsychological function in a peer-reviewed journal.
Prof. Baxendale later shared that in her 3 decades of academic publishing, the submission of the paper was truly a unique experience. She was not concerned that the paper had been rejected 3 times prior to being accepted. Rather, it was the nature of the rejections, which appeared to be ideologically driven. /3 onlinelibrary.wiley.com/doi/full/10.11…
Dr. Baxendale's full presentation at @segm_ebm NYC 2023 conference is available below. We will also highlight some key moments in the rest of this thread. /4
Dr. Baxendale explores what happens when critical windows of brain development are missed, starting with her "surprise" at the assertion made by proponents of youth transitions that puberty blockers are "completely reversible." /5
Prof. Baxendale challenges the claim that puberty can be paused & resumed:
“If you deprive the brain of any input during the critical windows of opportunity, the brain will move on and whatever it was that was supposed to be developing, doesn't develop properly.” /6
The process of pruning in the brain, which occurs during adolescence, is critical. It strengthens the executive function & social cognition. This process is hormonally driven: it depends on the pubertal stage, not on age. When puberty is stopped, brain development is affected./7
Prof. Baxendale's research was motivated by her surprise at the assertions by gender clinicians that "one can just pause puberty and then pick up 2-3 years later and nothing would happen," as this contradicted "everything we know about other windows of opportunity." /8
Dr. Baxendale found a paucity of studies on the effects of puberty blockers on human brains, so she turned to animal studies. What she found was that puberty blockers have “a detrimental impact on learning and the development of social behaviors and responses to stress." /9
Turning her attention to human studies, Prof. Baxendale found very few. Two studies were for the use of puberty blockers for early-onset puberty, and 3 were about stopping normally-timed puberty for gender-dysphoric youth. Several (low quality) studies signaled a drop in IQ. /10
Dr. Baxendale found no evidence that “you can pause a developmental stage and then restart it and everything will be okay.” Given all that is known about adolescent brain development, Dr. Baxendale asked a key question:
“How has this been allowed to develop as a treatment?”/11
The @NHSEngland's decision to restrict the use of puberty blockers to clinical research, finalized this month, vindicates Prof. Baxendale, Dr. Biggs, and other researchers in the UK and worldwide who have been sounding the alarm about the proliferation of puberty blockers in general medical settings without an adequate evidence base. /12
The full lecture by Prof. Baxendale at SEGM's NYC 2023 conference is profiled on our website and our YouTube channel. See links below. /end
Canada's public broadcaster aired a new documentary, Trans Express, underscoring the growing international concern with the practice of youth gender transitions. SEGM's NYC 2023 conference was profiled. /1
Dr. Littman was asked about her research into the surge in adolescent girls with no history of childhood gender dysphoria. Her research suggested a significant role of social influence and need for caution. /3
The American Psychological Association @APA has called for "efforts to address and rectify the dissemination of false information to ensure the well-being and dignity of transgender, gender-diverse, and nonbinary individuals."
It should heed its own advice. 🧵 /1
The APA's call for "the importance of an accurate understanding of evidence-based care" is welcome. Yet, the APA's definition of evidence-based medicine (EBM) bears no resemblance to how EBM is either understood or practiced in every other medical field in the 21st century. /2
While "continuous need for research" is a universal value, it should not be used as a shield to protect a field from scrutiny. Evidence-based medicine requires systematic scrutiny of the best available evidence. The practice of youth transitions now has 30+ years of evidence./3
Our recent Spotlight highlights a study from Finland, which convincingly demonstrates that suicides are uncommon in gender-dysphoric youth. The study demonstrates why youth gender transitions can’t be justified by the “suicide-prevention” argument./1
Using a robust methodology, the study estimated the suicide rate for GD youth at 0.3% (0.51/1,000 pt-yrs), with no evidence that transition reduced suicides. In summarizing clinic-reported rates, we noted that the highest suicide rates are coming from the transitioned cases./2
The study posed 3 questions about gender-dysphoric patients <23 yrs old: 1. Does the GD patients’ mortality rate, incl. suicide, differ from the control population? 2. Are the differences explained by psychiatric illness? 3. What’s the impact of gender transition on mortality?/3
On Jan 15, @WHO amended its previously described plans for "trans" (TGD) treatment guidelines. This was a response to worldwide concern about the effort's credibility. What makes guidelines trustworthy? An expert at SEGM's 2023 conference explains./1
Not all guidelines that claim to be evidence-based, are. Many are "consensus" guidelines developed using the "GOBSAT" method: good old boys sat around the table. This acronym was coined by a former WHO guideline expert who worked to promote rigor in guideline development. /2
Selecting the individuals who will comprise the guideline development group (GDG) is an early, key step. Credible GDGs should be multidisciplinary, include stakeholders w/ varied perspectives (clinicians, patients, and caregivers), and be free from conflicts of interest./3
The World Health Organization has announced the complete panel developing transgender health guidelines in 2024. The panel's unmanaged conflicts of interest will undermine the guidelines' credibility. Public comment deadline (hiv-aids@who.int) is Jan 8. /1 segm.org/world-health-o…
Besides a biased panel, 2 other key concerns are a short public comment period held over the Xmas & New Year's holiday, and a rushed guideline development process, with the group already scheduled to meet in February at the @WHO headquarters in Geneva to make decisions. /2
According to @WHO, management of conflicts of interest (COI) is essential to the development of unbiased and credible guidelines. This includes “any interest that could be reasonably perceived to affect an individual’s objectivity and independence while working with WHO.” /3
Do puberty blockers improve mental health? The original Dutch studies claimed so, but a replication attempt in the UK failed, finding no impact. A new peer-reviewed reanalysis of the UK data shows that up to 34% of youth actually "reliably deteriorated"./1 tandfonline.com/doi/full/10.10…
The original conclusions of the Dutch research in 2011/2014 claimed modest improvements in mental health of gender dysphoric minors following puberty blockers. The study's actual conclusions were quite modest yet they launched the practice of youth gender transitions worldwide./2
However, the Dutch puberty blocker study failed replication in the UK, despite closely matching the original Dutch study's methodology. The UK/Tavistock's disappointing study results had been known to the clinic for several years, but only published in 2021 after much pressure./3